Gore SD - Search Results

1

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes.

Silverman LR, Fenaux P, Mufti GJ, Santini V, Hellström-Lindberg E, Gattermann N, Sanz G, List AF, Gore SD, Seymour JF. Silverman LR, et al. Among authors: gore sd. Cancer. 2011 Jun 15;117(12):2697-702. doi: 10.1002/cncr.25774. Epub 2011 Jan 10. Cancer. 2011. PMID: 21656747 Free PMC article. Clinical Trial.

2

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, Löwenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL; World Health Organization(WHO) international working group. Cheson BD, et al. Among authors: gore s. Blood. 2000 Dec 1;96(12):3671-4. Blood. 2000. PMID: 11090046 Free article.

3

Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.

Gore SD, Weng LJ, Zhai S, Figg WD, Donehower RC, Dover GJ, Grever M, Griffin CA, Grochow LB, Rowinsky EK, Zabalena Y, Hawkins AL, Burks K, Miller CB. Gore SD, et al. Clin Cancer Res. 2001 Aug;7(8):2330-9. Clin Cancer Res. 2001. PMID: 11489809 Clinical Trial.

4

Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.

Gore SD, Weng LJ, Figg WD, Zhai S, Donehower RC, Dover G, Grever MR, Griffin C, Grochow LB, Hawkins A, Burks K, Zabelena Y, Miller CB. Gore SD, et al. Clin Cancer Res. 2002 Apr;8(4):963-70. Clin Cancer Res. 2002. PMID: 11948101 Clinical Trial.

5

Myelodysplastic syndrome.

Mufti G, List AF, Gore SD, Ho AY. Mufti G, et al. Among authors: gore sd. Hematology Am Soc Hematol Educ Program. 2003:176-99. doi: 10.1182/asheducation-2003.1.176. Hematology Am Soc Hematol Educ Program. 2003. PMID: 14633782 Review.

6

Six (or more) drugs in search of a mechanism: DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes.

Gore SD. Gore SD. J Natl Compr Canc Netw. 2006 Jan;4(1):83-90. doi: 10.6004/jnccn.2006.0009. J Natl Compr Canc Netw. 2006. PMID: 16403407 Review.

7

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.

Gore SD, Baylin S, Sugar E, Carraway H, Miller CB, Carducci M, Grever M, Galm O, Dauses T, Karp JE, Rudek MA, Zhao M, Smith BD, Manning J, Jiemjit A, Dover G, Mays A, Zwiebel J, Murgo A, Weng LJ, Herman JG. Gore SD, et al. Cancer Res. 2006 Jun 15;66(12):6361-9. doi: 10.1158/0008-5472.CAN-06-0080. Cancer Res. 2006. PMID: 16778214

8

Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches.

Gore SD, Hermes-DeSantis ER. Gore SD, et al. Cancer Control. 2008 Oct;15 Suppl(Suppl):40-9. doi: 10.1177/107327480801504s05. Cancer Control. 2008. PMID: 18813208 Free PMC article. Review.

9

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL Jr, Hahn T. Oliansky DM, et al. Among authors: gore sd. Biol Blood Marrow Transplant. 2009 Feb;15(2):137-72. doi: 10.1016/j.bbmt.2008.12.003. Biol Blood Marrow Transplant. 2009. PMID: 19167676 Free article. Review.

10

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Fenaux P, et al. Among authors: gore sd. Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21. Lancet Oncol. 2009. PMID: 19230772 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters